Urine and serum C-Reactive protein levels as potential biomarkers of lower urinary tract symptoms

Urological Science

Volumn 21, Issue 3, 2010, Pages 132-136

  Chuang, Yao Chi ^a   Tyagi, Vikas ^b   Liu, Rue Tsuan ^a   Chancellor, Michael B ^b   Tyagi, Pradeep ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Biomarker; CRP; LUTS

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; BACTERIAL INFECTION; CHRONIC PROSTATITIS; CONTROLLED STUDY; DETRUSOR MUSCLE; FEVER; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OVERACTIVE BLADDER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; REAL TIME POLYMERASE CHAIN REACTION; UROTHELIUM;

EID: 77957357568     PISSN: 18795226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1879-5226(10)60028-0     Document Type: Article

References (15)

1. Kupelian V, McVary KT, Barry MJ, et al. Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston area community health survey. Urology 2009, 73:950-957.
2. St.Sauver JL, Sarma AV, Jacobson DJ, et al. Association between C-reactive protein levels and longitudinal changes in urologic measures. J Urol 2008, 179:S30.
3. Kramer G, Mitteregger D, Marberger M Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?. Eur Urol 2007, 51:1202-1216.
4. Pontari MA, Ruggiori MR Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:839-845.
5. Kim JC, Park EY, Seo SI, Park YH, Hwang TK Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006, 175:1773-1776.
6. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997, 79:572-577.
7. Prasad K C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006, 24:33-50.
8. Liu HT, Tyagi P, Chancellor MB, Kuo HC Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 2009, 104:1476-1481.
9. Smaldone MC, Vodovotz Y, Tyagi V, et al. Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology 2009, 73:421-426.
10. Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score. Urology 2006, 68:318-323.
11. Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB Decreased sensory receptors P2×3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005, 174:977-982.
12. Shaarawy M, Zaki S, Sheiba M, El-Minawi AM Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Clin Lab 2003, 49:625-636.
13. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006, 7:R80.
14. Liu HT, Kuo HC Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008, 179:2270-2274.
15. Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y, Chancellor M Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 2009 Sep 26, [Epub ahead of print].